Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Rare Diseases × Collagenases × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Rare Diseases 1 Dupuytren Contracture 1 Connective Tissue Diseases 1 Arthritis 1

Interventions

tremelimumab 1 durvalumab 1 Streptozocin 1 Spironolactone 1 Specimen Handling 1 Radiosurgery 1 Radiation 1 Nivolumab 1 Mercaptopurine 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Leuprolide 1 Ipilimumab 1 Collagenases 1 Clomipramine 1 Carmustine 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00004409 2015-03-25

Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease

FDA Office of Orphan Products Development

Phase 2 Completed

Arthritis, Connective Tissue Diseases, Dupuytren Contracture, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡